APH vs BEAM · P/E 40, rev $23.09B vs rev $63.5M
Amphenol Corporation (APH) versus Beam Therapeutics Inc (BEAM) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
APH currently screens at market cap $170.77B and trailing P/E 39.9. BEAM currently screens at market cap $2.01B.
Not investment advice. Open the APH and BEAM stock pages for the full models.
Not investment advice.